You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Welcure Drugs & Pharmaceuticals Ltd"

Welcure Drugs & Pharmaceuticals Ltd Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Audited Acco

  • 18/04/2019
  • |
  • bse

Welcure Drugs & Pharmaceuticals Ltd Closure of Trading Window

  • 15/04/2019
  • |
  • bse

Welcure Drugs & Pharmaceuticals Ltd Compliance Certificate As Per Regulation 40(9) & 40(10) Issued By Practicing Company Secretary For T

  • 11/04/2019
  • |
  • bse

Welcure Drugs & Pharmaceuticals Ltd Compliances-Certificate under Reg. 54 (5) of SEBI (DP) Regulations 1996

  • 08/04/2019
  • |
  • bse

Welcure Drugs & Pharmaceuticals Ltd Compliance Certificate For The Period Ended March 2019

  • 08/04/2019
  • |
  • bse

Welcure Drugs & Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended March 2019

  • 08/04/2019
  • |
  • bse

Welcure Drugs & Pharmaceuticals Ltd Shareholding for the Period Ended March 31 2019

  • 05/04/2019
  • |
  • bse

Welcure Drugs & Pharmaceuticals Ltd Announcement Under Regulation 30(LODR) Sh. Nitin Singhal Non Executive Director Appointed As Chairm

  • 14/01/2019
  • |
  • bse

Welcure Drugs & Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Change in Directorate

  • 12/01/2019
  • |
  • bse

Welcure Drugs & Pharmaceuticals Ltd Un-Audited Financial Results For The Quarter Ended 31St December 2018 Along With Limited Review Repo

  • 12/01/2019
  • |
  • bse

Welcure Drugs & Pharmaceuticals Ltd Shareholding for the Period Ended December 31 2018

  • 05/01/2019
  • |
  • bse

Welcure Drugs & Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended December 2018

  • 05/01/2019
  • |
  • bse

Welcure Drugs & Pharmaceuticals Ltd Board Meeting Intimation for Considering Un-Audited Financial Results For The Quarter Ended 31-12-20

  • 02/01/2019
  • |
  • bse

Welcure Drugs & Pharmaceuticals Ltd Revised Compliance Certificate From Practicing Company Secretary Under Regulation 40(9) & 40(10) Of

  • 25/10/2018
  • |
  • bse

Welcure Drugs & Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication

  • 11/10/2018
  • |
  • bse

Welcure Drugs & Pharmaceuticals Ltd Outcome of Board Meeting

  • 08/10/2018
  • |
  • bse

Welcure Drugs & Pharmaceuticals Ltd Un-Audited Results For The Half Year And Quarter Ended 30.09.2018

  • 08/10/2018
  • |
  • bse

Welcure Drugs & Pharmaceuticals Ltd Announcement Under Regulation 30 Of SEBI ( Listing Obligations And Disclosure Requirement) Regulatio

  • 08/10/2018
  • |
  • bse

Welcure Drugs & Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Change in Directorate

  • 08/10/2018
  • |
  • bse

Welcure Drugs & Pharmaceuticals Ltd Certificate From Company Secretary In Practice Under Regulation 40(9) &(10) Of The SEBI( Listing Obl

  • 06/10/2018
  • |
  • bse